Climara vs. Bijuva

See how Climara and Bijuva compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Climara is a once-weekly estrogen-only patch, while Bijuva is a daily oral capsule combining bioidentical estradiol and progesterone.

  • Because Climara delivers estrogen alone, women with a uterus typically need a separate progestogen added to protect the uterine lining.

  • Both carry boxed warnings for blood clots, stroke, heart attack, and dementia risk in women 65 and older, though transdermal and oral estrogens carry somewhat different clot risk profiles.

Climara vs. Bijuva Drug Summary

Climara

Climara is a steroidal estrogen delivered through a once-weekly transdermal patch. It treats moderate to severe hot flashes and vaginal dryness from menopause, hormone deficiency from ovarian failure or castration, and helps prevent postmenopausal osteoporosis. The patch is changed once a week and comes in six strengths so a clinician can adjust the dose over time.

Bijuva

Bijuva is an oral capsule combining bioidentical estradiol and bioidentical progesterone in one pill. It is approved specifically to treat moderate to severe hot flashes in menopausal women who still have a uterus, since the progesterone component protects the uterine lining. It is taken once daily with food, which is needed for the progesterone to absorb properly.

Climara vs. Bijuva Side Effects

Climara

Most common
breast pain (≥10%)
headache (≥10%)
abdominal pain (≥10%)
generalized pain (≥10%)

Bijuva

Most common
breast tenderness (up to 4%)
headache (up to 4%)
nausea (up to 3.5%)
vaginal bleeding (up to 2.4%)

Climara vs. Bijuva Dosage

Climara

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.025 mg/day patch At the start
Maximum dose 0.1 mg/day patch If needed
Dose changes 5 increases As tolerated

Bijuva

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.5 mg/100 mg capsule At the start
Maximum dose 1 mg/100 mg capsule If needed
Dose changes 1 increase As tolerated

Climara vs. Bijuva Indications

Climara

Climara treats several menopause-related and hormone-deficiency conditions rather than hot flashes alone. It is also used off-label as part of feminizing hormone therapy. Its multiple patch strengths let clinicians tailor estrogen dosing to the specific condition being treated.

  • Moderate to severe menopausal hot flashes

  • Vaginal and vulvar atrophy from menopause

  • Hypoestrogenism from ovarian failure or castration

  • Prevention of postmenopausal osteoporosis

Bijuva

Bijuva has a single, narrower FDA approval: treating moderate to severe hot flashes in menopausal women who still have a uterus. It is not approved for osteoporosis prevention, vaginal atrophy, or use in women without a uterus. Its built-in progesterone makes it a self-contained option for women who need endometrial protection alongside estrogen.

  • Moderate to severe menopausal hot flashes

  • Only for women with an intact uterus

  • Not approved for osteoporosis prevention

  • Not approved for vaginal or vulvar atrophy

Climara vs. Bijuva Pros and Cons

Climara

Climara's transdermal delivery skips first-pass liver metabolism, which may lower clotting risk compared with oral estrogen, and its six patch strengths allow fine-tuned dosing. Because it delivers estrogen alone, most women with a uterus need to add a separate progestogen. It is also one of the most affordable estrogen therapies on the market.

Pros

  • Skips liver first-pass metabolism, potentially lowering VTE risk

  • Six patch strengths allow precise dose titration

  • Approved for osteoporosis prevention and vaginal atrophy, not just hot flashes

  • Roughly $19 to $59 per month, far less than Bijuva's cash price

Cons

  • Women with a uterus usually need a separate progestogen added

  • Patch can cause skin irritation or site reactions

  • Requires weekly site rotation and patch changes

  • Six different strengths can make initial dose selection more complex

Bijuva

Bijuva combines bioidentical estradiol and progesterone in one daily capsule, so women with a uterus get endometrial protection without a second prescription. Being an oral estrogen, it goes through liver metabolism, which may carry a different clot risk profile than a patch. It is also considerably more expensive and has no generic option.

Pros

  • Combines estrogen and progesterone in a single daily capsule

  • Uses bioidentical hormones matching the body's own estradiol and progesterone

  • No separate progestin prescription needed for uterine protection

  • Only two dose strengths simplify prescribing decisions

Cons

  • Oral dosing undergoes liver first-pass metabolism

  • Must be taken with food, and a high-fat meal changes absorption

  • No generic version currently available

  • Roughly $257 to $351 per month, much higher than Climara's list price

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.